PET imaging with 18F-florbetaben IDs Alzheimer's

04/2/2013 | MolecularImaging.net

Uptake of 18F-florbetaben on PET imaging scans was higher in the cerebral cortex of patients with Alzheimer's disease than in healthy study participants, according to a study published in the Journal of Nuclear Medicine. Researchers used a kinetic compartment theory of analysis for this study. "Compartment kinetic model-based quantification of [beta-amyloid] binding from 18F-florbetaben PET data is feasible, and all [beta-amyloid] binding parameters, including those by the reference tissue model and the practically useful SUVR, are excellent in discriminating between beta-amyloid–positive–and–negative scans," researchers said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY